Pathobiology of micro RNA in health and disease/ tumorigenesis Robbins based md pathology exam question easy explanation to replicate

Reading File
Finding Sources
Finding Sources
Searching PubMed

microRNA AND tumorigenesis

Searching the Web

Robbins pathology microRNA tumorigenesis oncogenes tumor suppressor genes

Reading File
Reading File

Pathobiology of microRNA in health, disease and tumorigenesis

1. What is microRNA?

MicroRNAs (miRNAs) are very small, non-coding RNA molecules, usually about 21-30 nucleotides long.
  • They are transcribed from DNA but do not make proteins.
  • Their function is to control how much protein is made from other genes.
  • One miRNA can regulate many different mRNAs, so it can control an entire group of cellular functions.
Simple definition for exam:
MicroRNAs are small non-coding RNAs that regulate gene expression after transcription by inhibiting translation or causing degradation of target mRNA.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 21.

2. Normal formation and action

Steps

  1. A miRNA gene is transcribed to form primary miRNA (pri-miRNA).
  2. It is processed in the nucleus into a hairpin-shaped pre-miRNA.
  3. Pre-miRNA moves to cytoplasm.
  4. The enzyme Dicer cuts it to form mature miRNA.
  5. One strand joins the RNA-induced silencing complex (RISC).
  6. The miRNA-RISC complex binds to a complementary target mRNA.
  7. It either:
    • destroys/cleaves the mRNA, or
    • blocks its translation into protein.

Flowchart to replicate

miRNA gene
    ↓ transcription
Primary miRNA (pri-miRNA)
    ↓ nuclear processing
Pre-miRNA hairpin
    ↓ export to cytoplasm
Dicer enzyme
    ↓
Mature miRNA
    ↓
RISC complex
    ↓ binds target mRNA
mRNA degradation OR inhibition of translation
    ↓
Decreased protein production
MicroRNA generation and action
The figure shows pri-miRNA processing, Dicer-mediated maturation and RISC-mediated post-transcriptional silencing. Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 21.

3. Role in health

In normal cells, miRNAs fine-tune gene expression. They are important in:
  • Embryonic development and cell differentiation
  • Cell proliferation
  • Apoptosis
  • Stem-cell maintenance
  • Immune responses
  • Tissue repair
  • Maintenance of normal cell identity

Easy analogy

Think of a gene as a protein-making factory.
  • DNA gives the order.
  • mRNA carries the order to the factory.
  • miRNA is like a brake or volume-control button.
  • It reduces protein production when the protein is not needed.
Thus, miRNAs help keep growth, survival and differentiation under control.

4. Role in disease

Abnormal miRNA expression causes inappropriate increase or decrease in protein synthesis.
This can contribute to:
  • Cancer
  • Cardiovascular disease
  • Inflammatory and autoimmune disorders
  • Neurologic diseases
  • Fibrosis
  • Metabolic disorders
The key principle is:
Abnormal miRNA → abnormal protein expression → disturbed cell function → disease

5. Role of microRNA in tumorigenesis

MicroRNAs are important in cancer because they can regulate genes involved in:
  • Cell-cycle progression
  • Apoptosis
  • DNA repair
  • Growth-factor signaling
  • Angiogenesis
  • Invasion and metastasis
Depending on the mRNA they inhibit, a miRNA can act either as:
  1. an oncogene, called an oncomiR, or
  2. a tumor suppressor.

A. miRNA acting as an oncogene: oncomiR

Normally, some miRNAs inhibit tumor-suppressor genes.
If such a miRNA is overexpressed, it excessively suppresses the tumor-suppressor protein.

Mechanism

Overexpression of oncogenic miRNA
          ↓
Suppression of tumor-suppressor mRNA
          ↓
Reduced tumor-suppressor protein
          ↓
Increased cell survival and proliferation
          ↓
Tumor formation / progression

Example: miR-21

miR-21 is commonly overexpressed in many cancers. It can suppress tumor-suppressive proteins such as PTEN, PDCD4, and others depending on the tumor context.
Result:
  • reduced apoptosis
  • increased proliferation
  • increased invasion and metastasis
One-line exam point:
Overexpression of miR-21 acts as an oncomiR by suppressing tumor-suppressor genes, thereby promoting tumor growth, invasion and metastasis.

B. miRNA acting as a tumor suppressor

Other miRNAs normally suppress proto-oncogenes or proteins that promote proliferation.
If these miRNAs are deleted or downregulated, the oncogenic target mRNAs are no longer inhibited.

Mechanism

Loss or reduced expression of tumor-suppressor miRNA
          ↓
Oncogene mRNA is no longer inhibited
          ↓
Increased oncoprotein synthesis
          ↓
Uncontrolled proliferation and reduced apoptosis
          ↓
Tumorigenesis

Example: let-7

The let-7 family normally inhibits oncogenes such as RAS.
Loss of let-7
      ↓
Increased RAS protein
      ↓
Increased proliferative signaling
      ↓
Cancer development
One-line exam point:
Loss of let-7 permits increased RAS expression and promotes tumorigenesis.

6. Why miRNA abnormalities occur in cancer

miRNA dysregulation may result from:
  • Deletion of miRNA genes
  • Amplification of miRNA genes
  • Chromosomal rearrangements
  • Abnormal DNA methylation or other epigenetic changes
  • Mutations affecting miRNA processing machinery, such as Dicer-related pathways
  • Altered transcription of miRNA genes

7. Final comparison table

FeatureOncogenic miRNA / OncomiRTumor-suppressor miRNA
Main abnormalityOverexpressionLoss or downregulation
Normal targetTumor-suppressor mRNAOncogene mRNA
Effect on target proteinDecreases tumor-suppressor proteinIncreases oncoprotein when miRNA is lost
ResultIncreased proliferation, survival, invasionIncreased proliferation and tumor formation
ExamplemiR-21let-7

8. Short-answer format for MD pathology exam

MicroRNAs are small non-coding RNAs, approximately 21-30 nucleotides long, that regulate gene expression post-transcriptionally. They are processed from primary miRNA transcripts and, after Dicer-mediated maturation, become incorporated into the RNA-induced silencing complex (RISC). The miRNA-RISC complex binds target mRNA and causes mRNA degradation or inhibition of translation.
In normal tissues, miRNAs regulate development, differentiation, proliferation, apoptosis and cellular homeostasis. In tumors, abnormal miRNA expression contributes to tumorigenesis by altering expression of oncogenes and tumor-suppressor genes. Overexpressed miRNAs may act as oncogenes, or oncomiRs, by suppressing tumor-suppressor mRNAs. For example, miR-21 can promote tumor growth and invasion through suppression of tumor-suppressive targets. Conversely, loss of tumor-suppressor miRNAs permits increased expression of oncogenes; for example, loss of let-7 can increase RAS expression. Thus, miRNA dysregulation can promote cell proliferation, inhibit apoptosis, and facilitate invasion and metastasis.

Memory trick

“miRNA = molecular inhibitor.”
  • More oncomiR → less tumor suppressor → cancer
  • Less tumor-suppressor miRNA → more oncogene → cancer
Recent reviews continue to support miRNA dysregulation as a contributor to tumor behavior and as a potential diagnostic or therapeutic biomarker, although the exact miRNAs and targets differ across cancers, such as in this 2025 colorectal-cancer review.
This is a shared conversation. Sign in to Orris to start your own chat.